Could your skin condition be affecting your heart? Psoriasis, a chronic skin disorder that affects millions, is more than just a cosmetic issue; it can lead to serious health problems like stroke. In a recent analysis of nearly 706,000 psoriasis patients, researchers found that those with severe psoriasis face a 36% higher risk of stroke compared to those without the condition. Even mild psoriasis isn't off the hook, with a 9% increased risk. This is particularly concerning because strokes can lead to significant disability or even death. The findings suggest that if you have psoriasis, especially if it’s severe or you're older, it’s essential to keep an eye on your heart health. Talk to your doctor about managing your cardiovascular risks. However, it’s important to remember that this research is just a starting point. We need more studies to understand why psoriasis increases stroke risk and how best to protect patients. Until then, staying informed and proactive about your health can make a big difference.
Psoriasis Linked to 24% Increased Stroke Risk, Especially in Severe CasesDoes Having Psoriasis Put You at Greater Risk for a Stroke?
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This meta-analysis systematically reviewed 18 observational studies comprising 705,602 psoriasis patients and 17,971,569 controls to assess stroke risk associated with psoriasis. Using a random-effects model, the pooled hazard ratio (HR) for stroke in psoriasis patients was found to be 1.24 (95% confidence intervals [CI]: 1.15-1.35, P<.05), indicating a 24% increased risk compared to controls. Stratification by disease severity revealed that patients with mild psoriasis had an HR of 1.09 (95% CI: 1.02-1.16), while those with severe psoriasis had a significantly higher risk with an HR of 1.36 (95% CI: 1.21-1.53). Regional analysis showed varying risk levels, with HRs of 1.08 in Asia, 1.26 in Europe, and 1.49 in North America. Age subgroup analysis confirmed the association across different age groups. No specific safety or adverse event data were reported in the meta-analysis. Clinically, these findings underscore the necessity for comprehensive cardiovascular risk management in psoriasis patients, particularly those with severe disease, to mitigate stroke risk. Further research is warranted to elucidate the mechanisms driving this increased risk.